DK3511015T3 - Genetisk stabil levende svækket respiratorisk syncytialvirusvaccine og fremstilling deraf - Google Patents

Genetisk stabil levende svækket respiratorisk syncytialvirusvaccine og fremstilling deraf Download PDF

Info

Publication number
DK3511015T3
DK3511015T3 DK19150800.1T DK19150800T DK3511015T3 DK 3511015 T3 DK3511015 T3 DK 3511015T3 DK 19150800 T DK19150800 T DK 19150800T DK 3511015 T3 DK3511015 T3 DK 3511015T3
Authority
DK
Denmark
Prior art keywords
manufacturing
respiratory syncytial
syncytial virus
virus vaccine
genetically stable
Prior art date
Application number
DK19150800.1T
Other languages
English (en)
Inventor
Peter L Collins
Cindy L Luongo
Ursula J Buchholz
Brian R Murphy
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK3511015T3 publication Critical patent/DK3511015T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18521—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18561—Methods of inactivation or attenuation
    • C12N2760/18562—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK19150800.1T 2012-04-13 2013-03-13 Genetisk stabil levende svækket respiratorisk syncytialvirusvaccine og fremstilling deraf DK3511015T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261624010P 2012-04-13 2012-04-13
EP13712641.3A EP2836231B1 (en) 2012-04-13 2013-03-13 Genetically stable live attenuated respiratory syncytial virus vaccine and its production

Publications (1)

Publication Number Publication Date
DK3511015T3 true DK3511015T3 (da) 2021-03-15

Family

ID=47998536

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19150800.1T DK3511015T3 (da) 2012-04-13 2013-03-13 Genetisk stabil levende svækket respiratorisk syncytialvirusvaccine og fremstilling deraf

Country Status (7)

Country Link
US (4) US9624475B2 (da)
EP (3) EP3875112A1 (da)
DK (1) DK3511015T3 (da)
ES (1) ES2863477T3 (da)
PL (1) PL3511015T3 (da)
PT (1) PT3511015T (da)
WO (1) WO2013154728A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9624475B2 (en) * 2012-04-13 2017-04-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Genetically stable live attenuated respiratory syncytial virus vaccine and its production
WO2017030997A1 (en) * 2015-08-14 2017-02-23 Research Institute At Nationwide Children's Hospital Respiratory syncytial virus having altered ns1 protein function and related materials and methods
US10655109B2 (en) * 2015-12-11 2020-05-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant respiratory syncytial virus stains with mutations in the M2-2 ORF providing a range of attenuation phenotypes
AU2023219791A1 (en) 2022-02-14 2024-08-22 University Of Georgia Research Foundation, Inc. Pan-pneumovirus vaccine compositions and methods of use thereof.
CN114574521B (zh) * 2022-03-03 2023-09-12 山东中医药大学 一种基于平衡补偿的重组流感病毒构建方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3224404A1 (de) 1982-06-30 1984-01-05 LuK Lamellen und Kupplungsbau GmbH, 7580 Bühl Reibungskupplung sowie verfahren zu deren montage
IL105456A (en) * 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus
US7846455B2 (en) * 1996-07-15 2010-12-07 The United States Of America As Represented By The Department Of Health And Human Services Attenuated chimeric respiratory syncytial virus
US6713066B1 (en) * 1996-07-15 2004-03-30 The United States Of America As Represented By The Department Of Health And Human Services Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
BR9710363A (pt) * 1996-07-15 2000-01-11 Us Gov Health & Human Serv "vìrus sincicial respirátorio recombinante infeccioso isolado, partìcula do mesmo, processos para estimular o sistema imunológico de um indivìduo para induzir proteção contra o vìrus sincicial respiratório e para produzir uma partìcula de vìrus sincicial respiratório recombinante, vacina para induzir proteção contra o vìrus sincicial respiratório recombinante composição e ceta de vìrus sincicial respiratório recombinante"
CN100354425C (zh) * 1999-07-09 2007-12-12 美国政府健康及人类服务部 减毒的人－牛嵌合呼吸道合胞病毒疫苗的生产
US9624475B2 (en) * 2012-04-13 2017-04-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Genetically stable live attenuated respiratory syncytial virus vaccine and its production

Also Published As

Publication number Publication date
EP3875112A1 (en) 2021-09-08
EP2836231A1 (en) 2015-02-18
EP2836231B1 (en) 2019-01-09
US20170189520A1 (en) 2017-07-06
US20150118732A1 (en) 2015-04-30
US10980872B2 (en) 2021-04-20
PT3511015T (pt) 2021-04-05
EP3511015B1 (en) 2020-12-30
US20190282690A1 (en) 2019-09-19
US20210330782A1 (en) 2021-10-28
US10307476B2 (en) 2019-06-04
US9624475B2 (en) 2017-04-18
WO2013154728A1 (en) 2013-10-17
PL3511015T3 (pl) 2021-09-13
EP3511015A1 (en) 2019-07-17
ES2863477T3 (es) 2021-10-11

Similar Documents

Publication Publication Date Title
HK1253909A1 (zh) 免疫缺陷的經遺傳修飾的嚙齒類及其使用方法
MA47787A (fr) Vaccin contre le virus respiratoire syncytial
DK2903600T3 (da) Virusholdig formulering og anvendelse deraf
MA46317A (fr) Vaccin contre le virus respiratoire syncytial
HK1216392A1 (zh) 流感病毒疫苗及其用途
DK3170508T3 (da) Vaccineformuleringer
HK1200102A1 (en) Influenza virus vaccines and uses thereof
DK3608325T3 (da) Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse
EP2552479A4 (en) INFLUENZA VIRUS VACCINES AND USES THEREOF
DK2941160T3 (da) Højeffektiv vindmodstandsdygtig kuglegrill
DK2855736T3 (da) Elektrolysator og energisystem
IL240504A0 (en) Combined vaccine for respiratory syncytial virus and influenza
DK3321287T3 (da) Fusionsproteiner og kombinationsvacciner
DK2823208T3 (da) Konnektor til åndedrætsveje
DK2547770T3 (da) Levende svækket kimær porcint circovirusvaccine
CO6811814A2 (es) Vacuna de virus dengue inactivado
DK2911676T3 (da) Hidtil ukendte mukosale adjuvanser og afgivelsessystemer
SG10201503450WA (en) Vaccine against beta-herpesvirus infection and use thereof
DK2806934T3 (da) Luftvejsanordning
DK2917181T3 (da) Heteroarylderivater og anvendelser deraf
SMT201700046B (it) Micobatterio ricombinante come vaccino
DK2809669T3 (da) Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika
EP2940134A4 (en) USING THE HUMAN PARAIN FLUENZAVIRUS TYPE 2 VEGETABLE VACCINE
HK1207312A1 (en) Temperature stable vaccine formulations
IL244354B (en) Flu vaccine and treatment